Wilmer Cutler Pickering Hale and Dorr represented Solid Biosciences in the offering, and Davis Polk & Wardwell represented the underwriters. Solid Biosciences Inc. (Nasdaq: SLDB) (“Solid”),...
You must be a Standard 1 Year member to access this content.
Wilmer Cutler Pickering Hale and Dorr represented KALA BIO, Inc. in the transaction. KALA BIO, Inc. (NASDAQ:KALA), a clinical-stage biopharmaceutical company, announced it had entered into...
You must be a Standard 1 Year member to access this content.
Wilmer Cutler Pickering Hale and Dorr advised Astria Therapeutics, Inc., and Cooley advised the underwriters. Astria Therapeutics, Inc. (Astria) (Nasdaq: ATXS) announced it completed its underwritten registered...
You must be a Standard 1 Year member to access this content.
Wilmer Cutler Pickering Hale and Dorr represented Inozyme Pharma and Shearman & Sterling represented the underwriters in the offering. Inozyme Pharma, Inc. announced the closing of its...
You must be a Standard 1 Year member to access this content.
Wilmer Cutler Pickering Hale and Dorr LLP advised Immuta on the deal. Immuta, the leading provider of cloud data access control, announced that it has secured...
You must be a Standard 1 Year member to access this content.
Wilmer Cutler Pickering Hale and Dorr LLP advised Immuta on the deal. Immuta, the leading provider of cloud data access control, announced that it has secured...
You must be a Standard 1 Year member to access this content.
